相关实验视频
Updated: Jun 5, 2025
11:20
Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
Published on: March 2, 2019
11.1K
在慢性阻塞性肺病中,巨细胞和微生物群
Karanjot K Sandhu1,2, Aaron Scott2, Amanda L Tatler3,4,5
1Department of Microbes, Infection and Microbiomes, Institute of Microbiology and Infection, School of Infection, Inflammation and Immunity, College of Medicine and Health, University of Birmingham, Birmingham, UK.
概括
慢性阻塞性肺病 (COPD) 的巨细胞显示细菌清除受损,可能与呼吸道微生物群变化有关. 本综述探讨了这些相互作用及其在疾病恶化中的作用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及到空气流量限制,慢性炎症和经常性细菌感染.
- 慢性肺炎患者表现出膜巨细胞增加,但细菌清除减少,导致恶化和肺功能下降.
- 在COPD中观察到功能障碍的巨细胞和改变的呼吸道微生物组合.
研究的目的:
- 审查目前关于COPD中巨细胞化缺陷的知识.
- 讨论COPD呼吸道微生物组的变化.
- 探索COPD中巨细胞和呼吸道微生物群之间的相互作用.
主要方法:
- 对COPD,巨细胞功能和呼吸道微生物组研究的文献综述.
- 对细菌清除和由膜和单细胞衍生巨细胞引起的细胞分裂的研究进行分析.
- 对研究COPD患者呼吸道微生物组合的研究进行审查.
主要成果:
- 在COPD中,巨细胞对病原性细菌的细胞能力降低.
- 慢性肺炎巨体对某些细菌属 (例如,Haemophilus,Moraxella,Streptococcus) 的选择性吸收.
- 低呼吸道微生物群的明显变化,病原性物种占主导地位,在COPD中很常见.
结论:
- 损坏的巨细胞化有助于COPD的复发性感染和恶化.
- 改变的呼吸道微生物组和功能障碍的巨细胞化之间的关系需要进一步调查.
- 了解这些相互作用对于管理COPD恶化和疾病进展至关重要.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:25Immune Surveillance by NK Cells and Phagocytes
1.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K